Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Raymond Fatig"'
Autor:
Maria V Tsiper, Jennifer Sturgis, Larisa V Avramova, Shilpa Parakh, Raymond Fatig, Ana Juan-García, Nianyu Li, Bartek Rajwa, Padma Narayanan, C W Qualls, J Paul Robinson, V Jo Davisson
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e45226 (2012)
Early evaluation of new drug entities for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. Multi-parametric high-content screening (mp-HCS) of mitochondrial toxicity holds promise as a lead in-vit
Externí odkaz:
https://doaj.org/article/b6c68ecb6bc142c08773a57eec5a927a
Autor:
Hong Jin, Andrew A. Bieberich, Elena Kutlina, Bartek Rajwa, Allison Irvine, Alexander Fekete, Laszlo Urban, Raymond Fatig
Publikováno v:
Journal of pharmacological and toxicological methods. 111
Excipients serve as vehicles, preservatives, solubilizers, and colorants for drugs, food, and cosmetics. They are considered to be inert at biological targets; however, several reports suggest that some could interact with human targets and cause unw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c35917b36c0bb6aa9e8ae9f394e156e
https://pubmed.ncbi.nlm.nih.gov/34144174
https://pubmed.ncbi.nlm.nih.gov/34144174
Autor:
Duncan Armstrong, Andrew Bieberich, Laszlo Urban, Ellen L. Berg, Alex Fekete, Raymond Fatig, Berengere Dumotier, Josh Pottel, Brian K. Shoichet, Vincent Shankey
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 93:148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93780e797fc5814ecaf6b62458a4ac9
https://doi.org/10.1016/j.vascn.2018.01.489
https://doi.org/10.1016/j.vascn.2018.01.489
Autor:
V. Jo Davisson, Bartek Rajwa, Ana Juan-García, Raymond Fatig, Charles W. Qualls, J. Paul Robinson, Larisa Avramova, Maria Tsiper, Padma K. Narayanan, Jennifer Sturgis, Nianyu Li, Shilpa Parakh
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e45226 (2012)
PLoS ONE, Vol 7, Iss 10, p e45226 (2012)
Early evaluation of new drug entities for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. Multi-parametric high-content screening (mp-HCS) of mitochondrial toxicity holds promise as a lead in-vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::472b4a6d432825344729e9f84893389d
http://europepmc.org/articles/PMC3471932
http://europepmc.org/articles/PMC3471932
PCNA, an essential protein in the DNA synthesis and repair, was shown to be phosphorylated at Y2111 by a nuclear kinase. A consequence of this post-transitional modification has been highly correlated with a reduced survival rate of breast cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d17439d3dfccf1ba64cc99b57478588b
https://doi.org/10.21236/ada554228
https://doi.org/10.21236/ada554228
Autor:
Giselle M. Knudsen, V. Jo Davisson, Roman V. Rozhkov, Dirk Schweitzer, J. Paul Robinson, Paul Helquist, Raymond Fatig
Publikováno v:
The FASEB Journal. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16071e5d5c7a92ab4ed0765029564c8b
https://doi.org/10.1096/fasebj.20.5.a941-c
https://doi.org/10.1096/fasebj.20.5.a941-c